Riskpilot← Back to searchSign inGet full accessAteta Specialistvård AB
ABActiveOrg 5568788276Norrlandsgatan 11 2trMedical specialists activities · NACE 8622Est. 20111-4 employees
Revenue 2025
SEK 5,9M
-1% vs 2024
EBITDA margin
6.1%
-50% vs 2024
Equity ratio
47.2%
Financial strength
Net profit 2025
SEK 257K
-59% vs 2024
| Revenue | SEK 5,9M | -1% |
| EBITDA | SEK 359K | -50% |
| Net profit | SEK 257K | -59% |
| Total assets | SEK 1,4M | -3% |
| Equity | SEK 678K | -17% |
| Employees | — | — |
Legal name
Ateta Specialistvård AB
Org number
5568788276
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 december 2011
Share capital
SEK 120 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska direkt eller indirekt bedriva verksamhet inom sjukvård och hälsovård, inkluderande utbildning, personalförmedling, samt därtill förenlig verksamhet.
Address
Norrlandsgatan 11 2tr
Phone
+468221210
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 023 | 4 791 | 4 188 | 5 956 | 5 878 |
| Staff expenses | — | −3 137 | −2 646 | −3 535 | −3 614 |
| EBITDA | −235 | 217 | 6 | 712 | 359 |
| Depreciation & amort. | −62 | −62 | −44 | −30 | −30 |
| EBIT | −297 | 154 | −38 | 682 | 329 |
| Net financials | — | −0 | 0 | 1 | 1 |
| Profit before tax | −297 | 154 | −38 | 683 | 330 |
| Tax | −0 | — | — | −56 | −73 |
| Net profit | −297 | 154 | −38 | 627 | 257 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 167 | 1 064 | 818 | 1 484 | 1 434 |
| Equity | 77 | 231 | 193 | 820 | 678 |
| Long-term debt | 20 | 0 | — | — | — |
| Short-term debt | 1 070 | 833 | 624 | 663 | 757 |
| Total debt | 1 090 | 833 | 624 | 663 | 757 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20212025
Equity ratio
47.2%
This company
38.2%
Market median
+24% vs market
20212025
Return on equity
38.0%
This company
18.4%
Market median
+107% vs market
20212025
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20212025
Asset turnover
4.10×
This company
1.12×
Market median
+266% vs market
20212025
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KL | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ateta Specialistvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klara Lisette Bengtsson | Audit | 0 companies |
| Dan Johan Ingemar Sandahl | Deputy Board Member | 0 companies |
| Susan Michaela Dörte Sandahl | Board of Directors | 0 companies |